Article information
Abstract
Phenotypic and genotypic SPM and IMP metallo-β-lactamases (MBL) detection and also the determination of minimal inhibitory concentrations (MIC) to imipenem, meropenem and ceftazidime were evaluated in 47 multidrug-resistant Pseudomonas aeruginosa isolates from clinical specimens. Polymerase chain reaction detected 14 positive samples to either blaSPM or blaIMP genes, while the best phenotypic assay (ceftazidime substrate and mercaptopropionic acid inhibitor) detected 13 of these samples. Imipenem, meropenem and ceftazidime MICs were higher for MBL positive compared to MBL negative isolates. We describe here the SPM and IMP MBL findings in clinical specimens of P. aeruginosa from the University Hospital of Botucatu Medical School, São Paulo, Brazil, that reinforce local studies showing the high spreading of blaSPM and blaIMP genes among Brazilian clinical isolates.
Keywords:
Pseudomonas aeruginosa
drug resistance, bacterial
carbapenems
metalloproteins
polymerase chain reaction
Full text is only available in PDF
References
[1.]
D. Livermore.
Beta-Lactamases in laboratory and clinical resistance.
Clin Microbiol Rev, 8 (1995), pp. 557-584
[2.]
K. Bush, G. Jacoby.
Updated functional classification of beta-lactamases.
Antimicrob Agents Chemother, 54 (2010), pp. 969-976
[3.]
A. Zavascki, A. Barth, A. Gonçalves, et al.
The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
J Antimicrob Chemother, 58 (2006), pp. 387-392
[4.]
A. Mastoraki, E. Douka, I. Kriaras, et al.
Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Surg Infect (Larchmt), 9 (2008), pp. 153-160
[5.]
Y. Lee, B. Ahn, J. Jin, et al.
Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
J Microbiol, 45 (2007), pp. 358-363
[6.]
T. Walsh, M. Toleman, L. Poirel, et al.
Metallo-beta-lactamases: the quiet before the storm?.
Clin Microbiol Rev, 18 (2005), pp. 306-325
[7.]
R. Picão, S. Andrade, A. Nicoletti, et al.
Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates.
J Clin Microbiol, 46 (2008), pp. 2028-2037
[8.]
J. Pitout, D. Gregson, L. Poirel, et al.
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory.
J Clin Microbiol, 43 (2005), pp. 3129-3135
[9.]
H. Sader, A. Reis, S. Silbert, A. Gales.
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenemresistant Pseudomonas aeruginosa in a Brazilian hospital.
Clin Microbiol Infect, 11 (2005), pp. 73-76
[10.]
R. Picão, L. Poirel, A. Gales, et al.
Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.
Antimicrob Agents Chemother, 53 (2009), pp. 3908-3913
[11.]
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
[12.]
Y. Doi, A. Ghilardi, J. Adams, et al.
High prevalence of metallobeta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
Antimicrob Agents Chemother, 51 (2007), pp. 3388-3390
[13.]
R. Bonomo, D. Szabo.
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
Clin Infect Dis, 43 (2006), pp. S49-S56
[14.]
V. Viana Vieira, E. Lourenço da Fonseca, A. Paulo Vincente.
Metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in Brazil.
Clin Microbiol Infect, 11 (2005), pp. 937
[15.]
E. Fonseca, F. Freitas, A. Vicente.
The colistin-only-sensitive (COS) Brazilian Pseudomonas aeruginosa clone SP (ST 277) is spread worldwide.
Antimicrob Agents Chemother, 54 (2010), pp. 2743
[16.]
A. Gales, L. Menezes, S. Silbert, et al.
Dissemination in distinct Brazilian regions of an epidemic carbapenemresistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
J Antimicrob Chemother, 52 (2003), pp. 699-702
[17.]
A. Martins, A. Zavascki, P. Gaspareto, et al.
Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Infection, 35 (2007), pp. 457-460
[18.]
L. Poirel, M. Magalhaes, M. Lopes, et al.
Molecular analysis of metallo-beta-lactamase gene bla (SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife. Brazil.
Antimicrob Agents Chemother, 48 (2004), pp. 1406-1409
[19.]
T. Gräf, D. Fuentefria, G. Corção.
Occurrence of multiresistant strains of Pseudomonas aeruginosa producing metallo-beta-lactamase blaSPM-1 in clinical samples.
Rev Soc Bras Med Trop, 41 (2008), pp. 306-308
[20.]
A. Salabi, M. Toleman, J. Weeks, et al.
First report of the metallo-beta-lactamase SPM-1 in Europe.
Antimicrob Agents Chemother, 54 (2010), pp. 582
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
